Open AccessCerebroprotein Hydrolysate: Innovation in Neurodegenerative Disorders
Author(s) -
Nidhi Jain,
Shailesh Kumar Yadav,
Manoj Goyal,
Kiran Kumar Singal,
Parveen Gupta,
M. Bansal
Publication year - 2014
Publication title -
international journal of medical and dental sciences
Language(s) - English
Resource type - Journals
eISSN - 2454-8952
pISSN - 2320-1118
DOI - 10.19056/ijmdsjssmes/2014/v3i1/80742
Subject(s) - medicine , neurotrophic factors , neuroscience , proteases , lesion , neurotrophin , hydrolysate , neurodegeneration , neuroplasticity , neuroprotection , neurotoxin , pharmacology , pathology , psychiatry , biology , receptor , biochemistry , disease , hydrolysis , enzyme
Stroke, traumatic brain injury and neurodegenerative disorders are one of the leading causes of death and disability in both developing and developed countries. A number of drugs including neurotrophic drugs are available for these disorders. Cerebroprotein hydrolysate is the latest one offering new hopes to patients suffering from these disorders. Its superiority is because of different actions which help in faster and more complete nerve repair and growth than other neurotrophic agents. It acts by multiple mechanisms viz. regulation and improvement of the neuronal metabolism, modulation of the synaptic plasticity, promoting neuronal differentiation and protection against ischemic and neurotoxin lesion, reducing excitotoxic damage, blocking over activation of calcium dependent proteases, and scavenging free oxygen radicals. Till now no serious adversity has been reported.